PRAZIQUANTEL CHALLENGE; UGANDA
PROVEN INTERVENTION TO BE DISTRIBUTED
Praziquantel, a de-worming drug.
Learn more about our current distribution challenges and why we focus on interventions that are proven to impact lives.
DISTRIBUTION MODEL INNOVATION
Kuisi will use mandatory teacher training meetings to train on, inform about, and mass distribute praziquantel, a deworming medicine, to high-risk areas in rural Uganda. Their strategy expands on the tried and tested school distribution model in several ways. First, they plan to distribute praziquantel through district wide, multi-purpose, teacher conferences. In addition to training the teachers on schistosomiasis and the distribution of praziquantel, they want to train the teachers on additional health and sanitation issues, as well as improved teaching methodologies. Kuisi has communicated with four additional institutions (UNESCO, Cherish Uganda, Africa Teacher Foundation, and TASO) that are already conducting teacher trainings and who are eager to provide additional information regarding their initiatives.
Kuisi addresses cost-effectiveness through incorporating overhead costs into school fees. These fees would go to pay for overhead costs and future scaling of the project. Currently the average school expenditures for primary and secondary schools respectively is $11.04 and $93.49 per student per year. If unable to work through public schools, they plan to increase the fees for private schools to make up the difference. Uganda has one of the highest percentages of students attending private schools. The initial pilot will gauge exactly how feasible school fees are, how much money we can receive, and how long-term they can last.
PILOT AND SCALING GOALS
- Deworm 50,000 children in the first month and a half
- Treat over 5 million people by the end of year 2